Immune effector dysfunction signatures predict outcomes in patients with colorectal cancer

CONCLUSION: CCR9, ISG20, ICOS, and CACNA2D2 were optimal IED signatures for predicting the outcomes of CRC patients, which might be a potential biomarker for prognostic stratification and designing novel CRC therapy.PMID:38552290 | DOI:10.1016/j.intimp.2024.111949

Source: International Immunopharmacology - March 29, 2024 Category: Allergy & Immunology Authors: Haifeng Tang Hongsheng Wu Yueju Jian Tengfei Ji Biwen Wu Yong Wu Peipei Wang Tiansheng Cao Source Type: research